Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective
Patel K, Yang D, Feldman H, Hsiung G, Nygaard H, Best J, Dwosh E, Robillard J, DeMarco M. Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2024, 10: e12463. PMID: 38596482, PMCID: PMC10999946, DOI: 10.1002/trc2.12463.Peer-Reviewed Original ResearchCare partnersSemi-structured phone interviewsCare partner perspectivesCare partners' experiencesPatients' decision-making processPre-test counsellingRoutine medical careBiomarker testingHealthy behaviorsCaregiving responsibilitiesPost-disclosureRoutine carePositive lifestyleLifestyle changesPhone interviewsMedical carePartners' experiencesCarePartner's perspectiveMedical interventionsAlzheimer's diseaseObservational studyClinic patientsStudy findingsPositive feelingsClinical value of Alzheimer's disease biomarker testing
Patel K, Yang D, Best J, Chambers C, Lee P, Henri‐Bhargava A, Funnell C, Foti D, Pettersen J, Feldman H, Nygaard H, Hsiung G, DeMarco M. Clinical value of Alzheimer's disease biomarker testing. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2024, 10: e12464. PMID: 38596484, PMCID: PMC10999950, DOI: 10.1002/trc2.12464.Peer-Reviewed Original ResearchAD biomarker testsHealth care resource useLevel of cognitive impairmentCare resource useLongitudinal cohort studyRoutine medical careAlzheimer's Disease DiagnosticHealth system economicsBiomarker testingClinical management planMedical decision-makingDementia specialistsMemory clinicIncreased referralsBaseline clinical presentationQuestionnaires pre-Increase patientsAD biomarker profileMedical careMedical utilizationFamily members' counselingManagement questionnaireCohort studyDrug prescriptionsPersonal utility